Interferon and amantadine in naive chronic hepatitis C: A double-blind, randomized, placebo-controlled trial-Reference-Cited by-同舟云学术

Interferon and amantadine in naive chronic hepatitis C: A double-blind, randomized, placebo-controlled trial

Published:2002-02 Issue:2 Volume:35 Page:447-454
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Helbling Beat,Stamenic Ivan,Viani Francesco,Gonvers Jean-Jacques,Dufour Jean-Francois,Reichen Jurg,Cathomas Gieri,Steuerwald Michael,Borovicka Jan,Sagmeister Markus,Renner Eberhard L.

Funder

Roche Pharma (Schweiz AG), Reinach, Switzerland, and Adroka AG, Allschwil, Switzerland

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1053/jhep.2002.31168/fullpdf

Reference43 articles.

1. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome;Alter;Semin Liver Dis,2000

2. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group;McHutchison;N Engl J Med,1998

3. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT);Poynard;Lancet,1998

4. Peginterferon alfa-2a in patients with chronic hepatitis C;Zeuzem;N Engl J Med,2000

5. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis;Heathcote;N Engl J Med,2000

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural Modification in Hepatitis C Virus Envelope Protein; Potential Viral Strategy Against Interferon Therapy;International Journal of Peptide Research and Therapeutics;2019-03-14

2. Molecular characterization and clinical epidemiology of HCV in District Dir (Lower), Pakistan;VirusDisease;2018-05-17

3. Epidemiology of Hepatitis C Infection in Pakistan: Current Estimate and Major Risk Factors;Critical Reviews in Eukaryotic Gene Expression;2017

4. Antiviral Drugs for Influenza and Other Respiratory Virus Infections;Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases;2015

5. Protective role of amantadine in mitochondrial dysfunction and oxidative stress mediated by hepatitis C virus protein expression;Biochemical Pharmacology;2014-06